Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Current Medical Research and Opinion
|
February 2, 2012
Predictors of remission with placebo using an integrated study database from patients with major depressive disorder
J C Nelson, Q Zhang, W Deberdt, et al.
Molecular Psychiatry
|
April 24, 2001
Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro
H F Seung Kim, E J Weeber, J D Sweatt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 7, 2017
Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression
J Koo, L B Marangell, M Nakamura, et al.
The Journal of Biological Chemistry
|
January 22, 2001
Protein kinase inhibition by omega-3 fatty acids
B Mirnikjoo, S E Brown, H F Kim, et al.
Biological Psychiatry
|
February 1, 1997
Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics
A M Callahan, M A Frye, L B Marangell, et al.
Archives of General Psychiatry
|
May 8, 1999
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial
A L Stoll, W E Severus, M P Freeman, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1995
The emerging role of cytochrome P450 3A in psychopharmacology
T A Ketter, D A Flockhart, R M Post, et al.
The Psychiatric Clinics of North America
|
January 9, 2001
Vagus nerve stimulation. A potential therapy for resistant depression?
M S George, H A Sackeim, L B Marangell, et al.
Archives of General Psychiatry
|
March 1, 1997
Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients
L B Marangell, M S George, A M Callahan, et al.
Psychopharmacology
|
November 1, 1996
The place of anticonvulsant therapy in bipolar illness
R M Post, T A Ketter, K Denicoff, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Current Medical Research and Opinion
|
February 2, 2012
Predictors of remission with placebo using an integrated study database from patients with major depressive disorder
J C Nelson, Q Zhang, W Deberdt, et al.
Molecular Psychiatry
|
April 24, 2001
Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro
H F Seung Kim, E J Weeber, J D Sweatt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 7, 2017
Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression
J Koo, L B Marangell, M Nakamura, et al.
The Journal of Biological Chemistry
|
January 22, 2001
Protein kinase inhibition by omega-3 fatty acids
B Mirnikjoo, S E Brown, H F Kim, et al.
Biological Psychiatry
|
February 1, 1997
Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics
A M Callahan, M A Frye, L B Marangell, et al.
Archives of General Psychiatry
|
May 8, 1999
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial
A L Stoll, W E Severus, M P Freeman, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1995
The emerging role of cytochrome P450 3A in psychopharmacology
T A Ketter, D A Flockhart, R M Post, et al.
The Psychiatric Clinics of North America
|
January 9, 2001
Vagus nerve stimulation. A potential therapy for resistant depression?
M S George, H A Sackeim, L B Marangell, et al.
Archives of General Psychiatry
|
March 1, 1997
Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients
L B Marangell, M S George, A M Callahan, et al.
Psychopharmacology
|
November 1, 1996
The place of anticonvulsant therapy in bipolar illness
R M Post, T A Ketter, K Denicoff, et al.
Page
of 4